3
Announcements
Trials
Browse
Landscape
Status
Terminated
1
Completed
1
Active not recruiting
1
Sponsor
Conditions
Breast Neoplasms
58
Ovarian Neoplasms
7
Neoplasm Metastasis
7
Endometrial Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Neoplasms
4
Hereditary Sensory and Autonomic Neuropathies
4
Advanced Breast Cancer
4
Uterine Cervical Neoplasms
3
Triple Negative Breast Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Colorectal Neoplasms
3
Neoplasms by Site
2
Head and Neck Neoplasms
2
Fallopian Tube Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Breast Diseases
2
Advanced Solid Tumors
2
Advanced Solid Tumor
2
Unilateral Breast Neoplasms
1
Spinocerebellar Degenerations
1
Salivary Gland Neoplasms
1
Recurrence
1
Prostatic Neoplasms
1
Melanoma
1
Lung Neoplasms
1
Locoregional Recurrence
1
Locally Advanced (Inoperable) or Metastatic Breast Cancer
1
HR+/HER2- Breast Cancer
1
HR+ Breast Cancer
1
Interventions
Oxaliplatin
42
Fluorouracil
27
Capecitabine
24
pembrolizumab
21
S 1 (combination)
19
Paclitaxel
19
Leucovorin
16
Nivolumab
13
Docetaxel
13
sintilimab
12
Drug Therapy
12
Trastuzumab
11
tislelizumab
10
Cisplatin
10
Irinotecan
9
Bevacizumab
8
trastuzumab deruxtecan
7
spartalizumab
7
XELOX
7
Surgical Procedures, Operative
7
Radiotherapy
7
Hyperthermic Intraperitoneal Chemotherapy
7
Biopsy
7
fludarabine
6
disitamab vedotin
6
Cyclophosphamide
6
lenvatinib
5
apatinib
5
Specimen Handling
5
Ramucirumab
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Recruiting
×
Stomach Neoplasms
×
Fulvestrant
×
Clear all
No trials found.